Pharmaceuticals Companies By Gross Profit

Gross Profit
Gross ProfitEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
2.99 T
 0.20 
 1.16 
 0.23 
2NVO Novo Nordisk AS
246.84 B
(0.09)
 2.85 
(0.25)
3RDY Dr Reddys Laboratories
184.65 B
(0.15)
 1.56 
(0.23)
4JNJ Johnson Johnson
61.79 B
 0.16 
 1.15 
 0.19 
5MRK Merck Company
49.47 B
(0.10)
 1.82 
(0.18)
6PFE Pfizer Inc
47.21 B
(0.03)
 1.18 
(0.03)
7AZN AstraZeneca PLC ADR
44.44 B
 0.16 
 1.17 
 0.19 
8NVS Novartis AG ADR
38.91 B
 0.20 
 1.35 
 0.27 
9LLY Eli Lilly and
36.62 B
 0.07 
 2.02 
 0.14 
10BMY Bristol Myers Squibb
36.35 B
 0.04 
 1.64 
 0.07 
11SNY Sanofi ADR
31.09 B
 0.17 
 1.36 
 0.23 
12GSK GlaxoSmithKline PLC ADR
22.53 B
 0.14 
 1.74 
 0.25 
13TEVA Teva Pharma Industries
8.06 B
(0.20)
 2.86 
(0.57)
14BHC Bausch Health Companies
6.84 B
(0.03)
 2.86 
(0.10)
15ZTS Zoetis Inc
6.54 B
(0.01)
 1.65 
(0.02)
16VTRS Viatris
6.14 B
(0.20)
 2.41 
(0.48)
17JAZZ Jazz Pharmaceuticals PLC
3.76 B
 0.08 
 1.70 
 0.13 
18OGN Organon Co
3.72 B
 0.02 
 2.79 
 0.04 
19ELAN Elanco Animal Health
2.44 B
(0.10)
 2.13 
(0.21)
20PRGO Perrigo Company PLC
1.54 B
 0.04 
 3.08 
 0.13 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments. Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.